CStone Pharmaceuticals (CSPHF)
USD 0.52
(0.0%)
USD 0.52
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 304.29 Million CNY | 9.31% |
| 2022 | 278.37 Million CNY | 103.36% |
| 2021 | 136.88 Million CNY | -82.83% |
| 2020 | 797.41 Million CNY | 0.0% |
| 2019 | - CNY | -100.0% |
| 2018 | 12.55 Million CNY | 21.84% |
| 2017 | 10.3 Million CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q4 | 19.54 Million USD | 0.0% |
| 2023 Q2 | 20.76 Million USD | 0.0% |
| 2023 FY | 304.29 Million CNY | 9.31% |
| 2022 FY | 278.37 Million CNY | 103.36% |
| 2022 Q4 | 14.15 Million USD | 0.0% |
| 2022 Q2 | 24.37 Million USD | 0.0% |
| 2021 FY | 136.88 Million CNY | -82.83% |
| 2021 Q2 | 5.94 Million USD | 0.0% |
| 2021 Q4 | 12.58 Million USD | 0.0% |
| 2020 Q4 | 116.6 Million USD | 0.0% |
| 2020 Q2 | -1.04 Million USD | 0.0% |
| 2020 FY | 797.41 Million CNY | 0.0% |
| 2019 Q4 | -914.34 Thousand USD | 0.0% |
| 2019 FY | - CNY | -100.0% |
| 2019 Q2 | -766.54 Thousand USD | 0.0% |
| 2018 Q3 | - CNY | 0.0% |
| 2018 FY | 12.55 Million CNY | 21.84% |
| 2018 Q4 | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 FY | 10.3 Million CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Evofem Biosciences, Inc. | 11.7 Million USD | -2499.479% |
| Arch Therapeutics, Inc. | -2439.00 USD | 12476319.762% |
| CSL Limited | 7.56 Billion USD | 95.975% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | -155.479% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -172246.511% |
| BioStem Technologies, Inc. | 15.42 Million USD | -1872.759% |
| Capstone Therapeutics Corp. | 9.61 Million USD | -3066.112% |
| Qrons Inc. | - USD | -Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 95338.915% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 1279.529% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -434607.143% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 245003.462% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 630645.598% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | -216480.071% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 25.701% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | -1928.769% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | -9809538.943% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| SQZ Biotechnologies Company | 9.79 Million USD | -3006.953% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -462860.991% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 891154.173% |
| Mesoblast Limited | -35.16 Million USD | 965.261% |
| Marizyme, Inc. | 457.7 Thousand USD | -66383.214% |
| Genus plc | 178.7 Million USD | -70.283% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| Pharming Group N.V. | 220.1 Million USD | -38.251% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | -488915.845% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -74088.436% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | 2766418.182% |
| ContraFect Corporation | -154 Thousand USD | 197694.156% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 608690.0% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -396318.754% |
| IMV Inc. | -962.29 Thousand USD | 31721.701% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 78627.539% |
| MultiCell Technologies, Inc. | 49.32 USD | -616980840.795% |
| ONE Bio Corp. | 20.12 Million USD | -1411.992% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | -655.731% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | -622180.164% |
| Q BioMed Inc. | -8988.00 USD | 3385669.648% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | -976.96% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | 1972966.961% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | -586.001% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 26755.787% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | -4952.00 USD | 6144990.953% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 312149.428% |
| GB Sciences, Inc. | -624.00 USD | 48765324.359% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 353816.232% |
| HST Global, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Halberd Corporation | -208.00 USD | 146295773.077% |
| Enzolytics Inc. | 30.7 Thousand USD | -990830.702% |
| Agentix Corp. | - USD | -Infinity% |
| Resverlogix Corp. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | -62975.08% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.1 Billion USD | 72.548% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 59242.679% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -49187.801% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | 3436132.069% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 363008.323% |
| Kadimastem Ltd | -630.13 Thousand USD | 48390.216% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | -30699.681% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| LadRx Corporation | -11.83 Thousand USD | 2571244.909% |
| Cell Source, Inc. | - USD | -Infinity% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -172246.511% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Affymax, Inc. | 1.35 Million USD | -22321.734% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| CytoDyn Inc. | -29 Thousand USD | 1049393.103% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | -67514.65% |
| SYBLEU INC | 11.69 Thousand USD | -2601601.436% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | -6503.624% |
| Bioxytran, Inc. | -8285.00 USD | 3672942.486% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | - USD | -Infinity% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 81680.429% |
| Neutra Corp. | 14.33 Thousand USD | -2122641.542% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 371191.463% |
| PureTech Health plc | -1.6 Million USD | 19082.845% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 30491.936% |
| IXICO plc | 3.27 Million USD | -9205.657% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 43946.542% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 17090.229% |
| CSL Limited | 7.7 Billion USD | 96.051% |
| Cellectis S.A. | 18 Thousand USD | -1690427.778% |